Popular Articles
Teeth Whitening Products

Osteotech Completes Enrollment For DuraTech(TM) BioRegeneration Matrix Clinical Trial
Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic products for regenerative healing, announced that it has completed enrollment for the clinical trial of its DuraTech(TM) BioRegeneration Matrix. Based upon Osteotech"s proprietary HCT(TM) (human collagen technology) platform, DuraTech is used to repair dura mater (the tough, outermost membrane surrounding the brain and spinal cord) during cranial surgical procedures.
generic viagra online
Complaints By The Elderly Valuable Information Or Trivialities?
What is done when the elderly lodge complaints about their services? elderly care? Why is it that staff describe complaints made by the elderly as "trivialities"? In two recent studies, Tove Persson, doctoral student at the School of Health Sciences, shows that staff, as well as social services directors in local administrations often trivialize complaints from the elderly, which in turn makes it difficult for the elderly to influence their everyday lives.
News of the day
Wheelchair Tai Chi - One Of The Simplest Ways For People Who Use Wheelchairs To Improve Their Physical And Mental Health
Studies overwhelmingly point to regular physical exercise as the crucial medicine for what ails Americans. Physicians have a hard time convincing even healthy patients to take action, but it"s a much harder sell for those with limited movement caused by physical disabilities. They often lack the self-confidence to begin a physical fitness plan, and it"s easy to understand why. They face transportation obstacles to visit an exercise facility. If they can get to the facility, accessing the building and equipment is often difficult or impossible, and fees are often high, says Dr. Zibin Guo, a medical anthropologist in The University of Tennessee at Chattanooga Department of Sociology, Anthropology, and Geography. He says appropriate and interesting exercise is often not available to this group.
Public Health

FDA Approves Besivance To Treat Bacterial Conjunctivitis

The U.S. Food and Drug Administration approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes. "Bacterial conjunctivitis is a common condition that affects people of all ages," said Wiley A. Chambers, M.D., acting director of the Division of Anti-Infective and Ophthalmology Products in FDA"s Center for Drug Evaluation and Research. "It is important to have a variety of treatment options available to health care professionals and patients because an effective drug therapy can reduce the duration of the illness and reduce the chances of infecting others." Bacterial forms of conjunctivitis are common in childhood, but they can occur in people of any age. Symptoms of bacterial conjunctivitis can include red eyes, swelling, eyelids sticking together, itching, watering and a white or yellow sticky discharge from the eyes. Bacterial conjunctivitis is generally a condition that runs its course in 7-14 days. Patients using the drug in clinical trials had a faster rate of resolution of the infection than those treated with a solution containing only a preservative. The drug was shown to be effective in treating patients age one year and older. Adverse events were reported in less than 3 percent of patients in clinical trials. Adverse reactions included redness of the eyes, blurred vision, eye pain, irritation and itching, and headache. Besivance is an eye drop for topical use on the eyes only. It should not be injected into the eye. Besivance is made by Bausch & Lomb, Rochester, N.Y. U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):